首页 > 市场调查报告书 > 医疗设备

心血管设备

市场调查报告书

商品编码

1469858

全球心臟帮浦设备市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Heart Pump Device Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年04月01日 | 出版商:

Value Market Research | 英文 175 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球心泵设备市场需求预计将从 2023 年的 39.2 亿美元达到近 203.6 亿美元的市场规模，2024 年至 2032 年的研究期间复合年增长率为 20.09%。

心臟帮浦装置，也称为心室辅助装置 (VAD) 或机械循环支援装置，用于替代或支持衰竭心臟的功能。它通常透过手术植入，帮助心臟将血液泵送到全身，减轻心臟衰竭症状并改善血液循环。它可以用作心臟移植的桥樑，作为不适合移植的个体的目标治疗，或作为心臟手术恢復期间的临时支持措施。

市场动态

冠状动脉疾病、心臟衰竭和心肌病等心血管疾病的盛行率不断增加，加上人口老化和生活方式因素，正在推动对心臟泵设备的需求，将其作为严重心臟衰竭患者的救生治疗选择。此外，医疗设备技术的进步，包括小型化、无线连接和感测器集成，使得下一代心臟泵设备的开发能够提高可靠性、耐用性和患者治疗效果。此外，越来越多的人接受机械循环支援装置，例如全人工心臟（TAH）和心室辅助装置（VAD）作为终末期心臟衰竭患者的标准护理治疗，正在推动市场扩张。

此外，心臟帮浦设备适应症的不断扩大，包括目的地治疗、移植桥和恢復桥，正在扩大适合设备植入的患者群体，并刺激市场成长。此外，越来越多地采用微创手术技术和经皮植入手术正在扩大治疗范围并推动市场渗透。此外，医疗设备製造商、医疗保健提供者和研究机构之间的策略合作和伙伴关係促进创新并加速先进心臟帮浦技术的开发和商业化。然而，报销政策的限制和替代疗法的竞争可能会挑战未来几年的市场成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球心臟帮浦设备市场的各个细分市场进行了包容性评估。心臟泵设备产业的成长和趋势为本研究提供了整体方法。

市场区隔

心臟帮浦设备市场报告的这一部分提供了国家和地区级别细分市场的详细资料，从而帮助策略师确定相应产品或服务的目标人口统计数据以及即将到来的机会。

按类型

植入式心臟帮浦装置
体外心臟帮浦装置

按产品分类

心室辅助装置 (VAD)（左心室辅助装置 (LVAD)、右心室辅助装置 (RVAD)、双心室辅助装置 (Bivad)、经皮心室辅助装置 (PVAD)）
全人工心臟 (TAH)
主动脉内球囊反搏 (IABP)
体外膜氧合（ECMO）

按最终用途

医院
心臟中心
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲心臟泵设备市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。心臟帮浦设备市场的主要参与者包括 Abbott、Abiomed、CorWave SA、LivaNova PLC、Berlin Heart、SynCardia Systems, LLC、Jarvik Heart、BiVACOR Inc.、Leviticus Cardio、Evaheart, Inc.、Teleflex Incorporated、Getinge AB.、卡马特(Carmat)、费森尤斯股份公司(Fresenius SE & Co. KgaA)。本节包含竞争格局的整体视图，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 9 章：心臟帮浦设备公司的竞争格局

心泵设备市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 10 章：公司简介

顶级公司市占率分析
市场集中度
Abbott

公司简介
公司收入
产品
最近的发展

Abiomed

公司简介
公司收入
产品
最近的发展

CorWave SA

公司简介
公司收入
产品
最近的发展

LivaNova PLC

公司简介
公司收入
产品
最近的发展

Berlin Heart

公司简介
公司收入
产品
最近的发展

SynCardia Systems LLC

公司简介
公司收入
产品
最近的发展

Jarvik Heart

公司简介
公司收入
产品
最近的发展

BiVACOR Inc.

公司简介
公司收入
产品
最近的发展

Leviticus Cardio

公司简介
公司收入
产品
最近的发展

Evaheart Inc.

公司简介
公司收入
产品
最近的发展

Teleflex Incorporated

公司简介
公司收入
产品
最近的发展

Getinge AB.

公司简介
公司收入
产品
最近的发展

Carmat

公司简介
公司收入
产品
最近的发展

Fresenius SE & Co. KgaA

公司简介
公司收入
产品
最近的发展

註 - 在公司概况中，财务详细资料和最新进展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR112114272

The global demand for Heart Pump Device Market is presumed to reach the market size of nearly USD 20.36 Billion by 2032 from USD 3.92 Billion in 2023 with a CAGR of 20.09% under the study period 2024 - 2032.

A heart pump device, also known as a ventricular assist device (VAD) or mechanical circulatory support device, is used to replace or support the function of a failing heart. It is typically implanted surgically and assists the heart in pumping blood throughout the body, alleviating symptoms of heart failure and improving circulation. It can be used as a bridge to heart transplantation, as a destination therapy for individuals ineligible for transplant, or as a temporary support measure during recovery from cardiac surgery.

MARKET DYNAMICS

The increasing prevalence of cardiovascular conditions, such as coronary artery disease, heart failure, and cardiomyopathy, coupled with an aging population and lifestyle factors, is driving the demand for heart pump devices as life-saving treatment options for patients with severe heart failure. Additionally, advancements in medical device technology, including miniaturization, wireless connectivity, and sensor integration, enable the development of next-generation heart pump devices with improved reliability, durability, and patient outcomes. Furthermore, the growing acceptance of mechanical circulatory support devices, such as total artificial hearts (TAHs) and ventricular assist devices (VADs), as standard-of-care treatments for end-stage heart failure patients is driving market expansion.

Moreover, the expanding indications for heart pump devices, including destination therapy, bridge-to-transplantation, and bridge-to-recovery, are widening the patient population eligible for device implantation and stimulating market growth. Additionally, the increasing adoption of minimally invasive surgical techniques and percutaneous implantation procedures is expanding access to treatment and driving market penetration. Furthermore, strategic collaborations and partnerships between medical device manufacturers, healthcare providers, and research institutions foster innovation and accelerate the development and commercialization of advanced heart pump technologies. However, limitations in reimbursement policies and competition from alternative treatments may challenge the market growth in the coming years.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of heart pump device. The growth and trends of heart pump device industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the heart pump device market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Implanted Heart Pump Devices
Extracorporeal Heart Pump Devices

By Product

Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (Bivad), Percutaneous Ventricular Assist Devices (PVAD))
Total Artificial Hearts (TAHs)
Intra-Aortic Balloon Pumps (IABPs)
Extracorporeal Membrane Oxygenation (ECMO)

By End-Use

Hospitals
Cardiac Centers
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Heart Pump Device market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Heart Pump Device market include Abbott, Abiomed, CorWave SA, LivaNova PLC, Berlin Heart, SynCardia Systems, LLC, Jarvik Heart, BiVACOR Inc., Leviticus Cardio, Evaheart, Inc., Teleflex Incorporated, Getinge AB., Carmat, Fresenius SE & Co. KgaA. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. HEART PUMP DEVICE - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Type
- 3.7.2 Market Attractiveness Analysis By Product
- 3.7.3 Market Attractiveness Analysis By End-Use
- 3.7.4 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY TYPE

5.1. Overview By Type
5.2. Historical and Forecast Data
5.3. Analysis By Type
5.4. Implanted Heart Pump Devices Historic and Forecast Sales By Regions
5.5. Extracorporeal Heart Pump Devices Historic and Forecast Sales By Regions

6. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY PRODUCT

6.1. Overview By Product
6.2. Historical and Forecast Data
6.3. Analysis By Product
6.4. Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD), Percutaneous Ventricular Assist Devices (PVAD)) Historic and Forecast Sales By Regions
6.5. Total Artificial Hearts (TAHs) Historic and Forecast Sales By Regions
6.6. Intra-Aortic Balloon Pumps (IABPs) Historic and Forecast Sales By Regions
6.7. Extracorporeal Membrane Oxygenation (ECMO) Historic and Forecast Sales By Regions

7. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY END-USE

7.1. Overview By End-Use
7.2. Historical and Forecast Data
7.3. Analysis By End-Use
7.4. Hospitals Historic and Forecast Sales By Regions
7.5. Cardiac Centers Historic and Forecast Sales By Regions
7.6. Others Historic and Forecast Sales By Regions

8. GLOBAL HEART PUMP DEVICE MARKET ANALYSIS BY GEOGRAPHY

8.1. Regional Outlook
8.2. Introduction
8.3. North America Sales Analysis
- 8.3.1 Overview, Historic and Forecast Data Sales Analysis
- 8.3.2 North America By Segment Sales Analysis
- 8.3.3 North America By Country Sales Analysis
- 8.3.4 United States Sales Analysis
- 8.3.5 Canada Sales Analysis
- 8.3.6 Mexico Sales Analysis
8.4. Europe Sales Analysis
- 8.4.1 Overview, Historic and Forecast Data Sales Analysis
- 8.4.2 Europe By Segment Sales Analysis
- 8.4.3 Europe By Country Sales Analysis
- 8.4.4 United Kingdom Sales Analysis
- 8.4.5 France Sales Analysis
- 8.4.6 Germany Sales Analysis
- 8.4.7 Italy Sales Analysis
- 8.4.8 Russia Sales Analysis
- 8.4.9 Rest Of Europe Sales Analysis
8.5. Asia Pacific Sales Analysis
- 8.5.1 Overview, Historic and Forecast Data Sales Analysis
- 8.5.2 Asia Pacific By Segment Sales Analysis
- 8.5.3 Asia Pacific By Country Sales Analysis
- 8.5.4 China Sales Analysis
- 8.5.5 India Sales Analysis
- 8.5.6 Japan Sales Analysis
- 8.5.7 South Korea Sales Analysis
- 8.5.8 Australia Sales Analysis
- 8.5.9 South East Asia Sales Analysis
- 8.5.10 Rest Of Asia Pacific Sales Analysis
8.6. Latin America Sales Analysis
- 8.6.1 Overview, Historic and Forecast Data Sales Analysis
- 8.6.2 Latin America By Segment Sales Analysis
- 8.6.3 Latin America By Country Sales Analysis
- 8.6.4 Brazil Sales Analysis
- 8.6.5 Argentina Sales Analysis
- 8.6.6 Peru Sales Analysis
- 8.6.7 Chile Sales Analysis
- 8.6.8 Rest of Latin America Sales Analysis
8.7. Middle East & Africa Sales Analysis
- 8.7.1 Overview, Historic and Forecast Data Sales Analysis
- 8.7.2 Middle East & Africa By Segment Sales Analysis
- 8.7.3 Middle East & Africa By Country Sales Analysis
- 8.7.4 Saudi Arabia Sales Analysis
- 8.7.5 UAE Sales Analysis
- 8.7.6 Israel Sales Analysis
- 8.7.7 South Africa Sales Analysis
- 8.7.8 Rest Of Middle East And Africa Sales Analysis

9. COMPETITIVE LANDSCAPE OF THE HEART PUMP DEVICE COMPANIES

9.1. Heart Pump Device Market Competition
9.2. Partnership/Collaboration/Agreement
9.3. Merger And Acquisitions
9.4. New Product Launch
9.5. Other Developments

10. COMPANY PROFILES OF HEART PUMP DEVICE INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Market Concentration Rate
10.3. Abbott
- 10.3.1 Company Overview
- 10.3.2 Company Revenue
- 10.3.3 Products
- 10.3.4 Recent Developments
10.4. Abiomed
- 10.4.1 Company Overview
- 10.4.2 Company Revenue
- 10.4.3 Products
- 10.4.4 Recent Developments
10.5. CorWave SA
- 10.5.1 Company Overview
- 10.5.2 Company Revenue
- 10.5.3 Products
- 10.5.4 Recent Developments
10.6. LivaNova PLC
- 10.6.1 Company Overview
- 10.6.2 Company Revenue
- 10.6.3 Products
- 10.6.4 Recent Developments
10.7. Berlin Heart
- 10.7.1 Company Overview
- 10.7.2 Company Revenue
- 10.7.3 Products
- 10.7.4 Recent Developments
10.8. SynCardia Systems LLC
- 10.8.1 Company Overview
- 10.8.2 Company Revenue
- 10.8.3 Products
- 10.8.4 Recent Developments
10.9. Jarvik Heart
- 10.9.1 Company Overview
- 10.9.2 Company Revenue
- 10.9.3 Products
- 10.9.4 Recent Developments
10.10. BiVACOR Inc.
- 10.10.1 Company Overview
- 10.10.2 Company Revenue
- 10.10.3 Products
- 10.10.4 Recent Developments
10.11. Leviticus Cardio
- 10.11.1 Company Overview
- 10.11.2 Company Revenue
- 10.11.3 Products
- 10.11.4 Recent Developments
10.12. Evaheart Inc.
- 10.12.1 Company Overview
- 10.12.2 Company Revenue
- 10.12.3 Products
- 10.12.4 Recent Developments
10.13. Teleflex Incorporated
- 10.13.1 Company Overview
- 10.13.2 Company Revenue
- 10.13.3 Products
- 10.13.4 Recent Developments
10.14. Getinge AB.
- 10.14.1 Company Overview
- 10.14.2 Company Revenue
- 10.14.3 Products
- 10.14.4 Recent Developments
10.15. Carmat
- 10.15.1 Company Overview
- 10.15.2 Company Revenue
- 10.15.3 Products
- 10.15.4 Recent Developments
10.16. Fresenius SE & Co. KgaA
- 10.16.1 Company Overview
- 10.16.2 Company Revenue
- 10.16.3 Products
- 10.16.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Type (USD MN)
Implanted Heart Pump Devices Market Sales By Geography (USD MN)
Extracorporeal Heart Pump Devices Market Sales By Geography (USD MN)
Analysis By Product (USD MN)
Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD), Percutaneous Ventricular Assist Devices (PVAD)) Market Sales By Geography (USD MN)
Total Artificial Hearts (TAHs) Market Sales By Geography (USD MN)
Intra-Aortic Balloon Pumps (IABPs) Market Sales By Geography (USD MN)
Extracorporeal Membrane Oxygenation (ECMO) Market Sales By Geography (USD MN)
Analysis By End-Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Cardiac Centers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Heart Pump Device Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition

LIST OF FIGURES

Research Scope of Heart Pump Device Report
Market Research Process
Market Research Methodology
Global Heart Pump Device Market Size, By Region (USD MN)
Porters Five Forces Analysis
Market Attractiveness Analysis By Type
Market Attractiveness Analysis By Product
Market Attractiveness Analysis By End-Use
Market Attractiveness Analysis By Region
Value Chain Analysis
Global Market Analysis By Type (USD MN)
Implanted Heart Pump Devices Market Sales By Geography (USD MN)
Extracorporeal Heart Pump Devices Market Sales By Geography (USD MN)
Global Market Analysis By Product (USD MN)
Ventricular Assist Devices (VADs) (Left Ventricular Assist Devices (LVAD), Right Ventricular Assist Devices (RVAD), Bi-Ventricular Assist Devices (BiVAD), Percutaneous Ventricular Assist Devices (PVAD)) Market Sales By Geography (USD MN)
Total Artificial Hearts (TAHs) Market Sales By Geography (USD MN)
Intra-Aortic Balloon Pumps (IABPs) Market Sales By Geography (USD MN)
Extracorporeal Membrane Oxygenation (ECMO) Market Sales By Geography (USD MN)
Global Market Analysis By End-Use (USD MN)
Hospitals Market Sales By Geography (USD MN)
Cardiac Centers Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Market Sales (USD MN)
North America Market Sales (USD MN)
Europe Market Sales (USD MN)
Asia Pacific Market Sales (USD MN)
Latin America Market Sales (USD MN)
Middle East & Africa Market Sales (USD MN)
Recent Development in Industry
Top Company Market Share Analysis